Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: RETRACTED ARTICLE: Azoramide, a novel regulator, favors adipogenesis against osteogenesis through inhibiting the GLP-1 receptor-PKA-β-catenin pathway

Fig. 6

Decreased expression levels of protein kinase A (PKA) with azoramide (Azo) treatment. a, b Western blot of Runt-related transcription factor 2 (Runx2) and PKAc proteins in C3H10T1/2 cells subjected to different treatments. c Alkaline phosphatase (ALP) staining of cells pretreated with azoramide followed by Forskolin treatment. Scale bar = 100 μm

Back to article page